These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35762561)

  • 41. Inflammatory proteomics profiling for prediction of incident atrial fibrillation.
    Börschel CS; Ortega-Alonso A; Havulinna AS; Jousilahti P; Salmi M; Jalkanen S; Veikko S; Niiranen T; Schnabel RB
    Heart; 2023 Jun; 109(13):1000-1006. PubMed ID: 36801832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interrelations between albuminuria, electrocardiographic left atrial abnormality, and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA) cohort.
    Ahmad MI; Chen LY; Singh S; Luqman-Arafath TK; Kamel H; Soliman EZ
    Int J Cardiol; 2023 Jul; 383():102-109. PubMed ID: 37100232
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting Value of Growth Differentiation Factor 15 and Its Correlations With Atrial Fibrillation.
    Zhou J; Kang Z; Liu L; Guo Y; Chen S
    Heart Surg Forum; 2020 Jul; 23(4):E452-E460. PubMed ID: 32726227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
    Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
    Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exploration of pathophysiological pathways for incident atrial fibrillation using a multiplex proteomic chip.
    Molvin J; Jujic A; Melander O; Pareek M; Råstam L; Lindblad U; Daka B; Leosdottir M; Nilsson P; Olsen M; Magnusson M
    Open Heart; 2020; 7(1):e001190. PubMed ID: 32201587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of Atrial Fibrillation With Cognitive Decline and Dementia Over 20 Years: The ARIC-NCS (Atherosclerosis Risk in Communities Neurocognitive Study).
    Chen LY; Norby FL; Gottesman RF; Mosley TH; Soliman EZ; Agarwal SK; Loehr LR; Folsom AR; Coresh J; Alonso A
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Higher Cumulative Blood Pressure in Midlife Predicts an Increased Risk of Atrial Fibrillation: Evidence From the Atherosclerosis Risk in Communities Study.
    Cheng YJ; Deng H; Ling Y; Lin WD; Liang Z; Chen Y; Fang XH; Liao HT; Liu Y; Wei HQ; Liu FZ; Jiang JR; Wu SL; Xue YM; Wu Z
    J Am Heart Assoc; 2023 Dec; 12(24):e030409. PubMed ID: 38084710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study.
    Lopez FL; Agarwal SK; Maclehose RF; Soliman EZ; Sharrett AR; Huxley RR; Konety S; Ballantyne CM; Alonso A
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):155-62. PubMed ID: 22227953
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of serum uric acid with incident atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study).
    Tamariz L; Agarwal S; Soliman EZ; Chamberlain AM; Prineas R; Folsom AR; Ambrose M; Alonso A
    Am J Cardiol; 2011 Nov; 108(9):1272-6. PubMed ID: 21855838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atrial ectopy and N-terminal pro-B-type natriuretic peptide as predictors of atrial fibrillation: a population-based cohort study.
    Kumarathurai P; Mouridsen MR; Mattsson N; Larsen BS; Nielsen OW; Gerds TA; Sajadieh A
    Europace; 2017 Mar; 19(3):364-370. PubMed ID: 27194537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study.
    Soliman EZ; Lopez F; O'Neal WT; Chen LY; Bengtson L; Zhang ZM; Loehr L; Cushman M; Alonso A
    Circulation; 2015 May; 131(21):1843-50. PubMed ID: 25918127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Communities (ARIC) Study.
    Magnani JW; Norby FL; Agarwal SK; Soliman EZ; Chen LY; Loehr LR; Alonso A
    JAMA Cardiol; 2016 Jul; 1(4):433-41. PubMed ID: 27438320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-sensitivity cardiac troponin I and risk of incident atrial fibrillation hospitalisation in an Australian community-based cohort: The Busselton health study.
    Zhu K; Hung J; Divitini M; Murray K; Lim EM; St John A; Walsh JP; Knuiman M
    Clin Biochem; 2018 Aug; 58():20-25. PubMed ID: 29746826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study.
    Al Rifai M; Schneider AL; Alonso A; Maruthur N; Parrinello CM; Astor BC; Hoogeveen RC; Soliman EZ; Chen LY; Ballantyne CM; Halushka MK; Selvin E
    J Diabetes Complications; 2015 Mar; 29(2):180-5. PubMed ID: 25499973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Simple risk model and score for predicting of incident atrial fibrillation in Japanese.
    Hamada R; Muto S
    J Cardiol; 2019 Jan; 73(1):65-72. PubMed ID: 30064946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum Metabolomics and Incidence of Atrial Fibrillation (from the Atherosclerosis Risk in Communities Study).
    Alonso A; Yu B; Sun YV; Chen LY; Loehr LR; O'Neal WT; Soliman EZ; Boerwinkle E
    Am J Cardiol; 2019 Jun; 123(12):1955-1961. PubMed ID: 30979411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biomarker-Based Risk Prediction With the ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation.
    Benz AP; Hijazi Z; Lindbäck J; Connolly SJ; Eikelboom JW; Oldgren J; Siegbahn A; Wallentin L
    Circulation; 2021 May; 143(19):1863-1873. PubMed ID: 33849281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
    Pol T; Hijazi Z; Lindbäck J; Oldgren J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Granger CB; Lopes RD; Yusuf S; Siegbahn A; Wallentin L
    Cardiovasc Res; 2022 Jul; 118(9):2112-2123. PubMed ID: 34358298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A polygenic risk score of atrial fibrillation improves prediction of lifetime risk for heart failure.
    Alkis T; Luo X; Wall K; Brody J; Bartz T; Chang PP; Norby FL; Hoogeveen RC; Morrison AC; Ballantyne CM; Coresh J; Boerwinkle E; Psaty BM; Shah AM; Yu B
    ESC Heart Fail; 2024 Apr; 11(2):1086-1096. PubMed ID: 38258344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities study.
    Echouffo-Tcheugui JB; Daya N; Ndumele CE; Matsushita K; Hoogeveen RC; Ballantyne CM; Coresh J; Shah AM; Selvin E
    Diabetologia; 2022 Jun; 65(6):955-963. PubMed ID: 35275240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.